MacroGenics Investors Urged to Act Important Class Action Deadline Approaches | CSIMarket News

MacroGenics Investors Urged to Act Important Class Action Deadline Approaches

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

In a noteworthy development for investors involved with MacroGenics, Inc. (NASDAQ: MGNX), which spans the period from March 7, 2024, to May 9, 2024, both the Rosen Law Firm and Robbins Geller Rudman & Dowd LLP are urging affected stakeholders to take action before a critical deadline. The two distinguished law firms are advocating for individuals who purchased stock or sold puts during this timeframe to secure legal counsel in light of an impending lead plaintiff deadline set for September 24, 2024.

The context for this situation revolves around a class action lawsuit initiated under the
Sources for this article: Based on Macrogenics Inc ’s official statement and CSIMarket.com Customer Analytics Research for Macrogenics Inc
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#Announcement, #MacroGenicsIncIncTopazMeltzerFaruqiCompany, #customers, #Inc.MarchCheckNewYorkSuch, #MGNXUnitedStatesDistrictCourtPennsylvaniaDaniellePeyton, #ClassActionDistrictCalifornia, #CompanyAnnouncementStockStock, #MGNX, #Macrogenics Inc, #Major Pharmaceutical Preparations
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License